SC 13G

Company

Acrivon Therapeutics, Inc.

Filed

November 21, 2022

Accession Number

0001104659-22-120743

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →